[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX2016006165A - Composiciones y metodos para valorar la funcion intestinal. - Google Patents

Composiciones y metodos para valorar la funcion intestinal.

Info

Publication number
MX2016006165A
MX2016006165A MX2016006165A MX2016006165A MX2016006165A MX 2016006165 A MX2016006165 A MX 2016006165A MX 2016006165 A MX2016006165 A MX 2016006165A MX 2016006165 A MX2016006165 A MX 2016006165A MX 2016006165 A MX2016006165 A MX 2016006165A
Authority
MX
Mexico
Prior art keywords
compositions
methods
gut function
assessing gut
assessing
Prior art date
Application number
MX2016006165A
Other languages
English (en)
Inventor
B Dorshow Richard
J Hanley Steven
I Tarr Phillip
Original Assignee
B Dorshow Richard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Dorshow Richard filed Critical B Dorshow Richard
Publication of MX2016006165A publication Critical patent/MX2016006165A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Se dan a conocer composiciones y métodos para valorar la función intestinal. Los mismos se diseñan para proporcionar una valoración exacta, rápida, en el centro de atención o colectiva de la disfunción entérica.
MX2016006165A 2013-11-11 2014-11-12 Composiciones y metodos para valorar la funcion intestinal. MX2016006165A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361902637P 2013-11-11 2013-11-11
PCT/US2014/065233 WO2015070256A1 (en) 2013-11-11 2014-11-12 Compositions and methods for assessing gut function

Publications (1)

Publication Number Publication Date
MX2016006165A true MX2016006165A (es) 2016-09-13

Family

ID=53042261

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006165A MX2016006165A (es) 2013-11-11 2014-11-12 Composiciones y metodos para valorar la funcion intestinal.

Country Status (10)

Country Link
US (4) US11077211B2 (es)
EP (2) EP3068399B1 (es)
JP (3) JP2016535102A (es)
CN (4) CN110251691A (es)
AU (1) AU2014346386B2 (es)
CA (1) CA2930387C (es)
IL (1) IL245602B2 (es)
MX (1) MX2016006165A (es)
NZ (1) NZ719971A (es)
WO (1) WO2015070256A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6782886B2 (ja) * 2017-01-19 2020-11-11 国立大学法人島根大学 腸粘膜の透過性の診断薬、診断方法、診断装置
WO2018177381A1 (zh) * 2017-03-30 2018-10-04 合肥合源药业有限公司 乳果糖糖苷化合物、其制备方法及其用途
WO2019084425A1 (en) * 2017-10-27 2019-05-02 Medibeacon Inc. METHODS FOR EVALUATING RENAL FUNCTION
AU2018355541B2 (en) 2017-10-27 2020-11-19 Medibeacon Inc. Compositions and systems for renal function determination
SG11202106309QA (en) 2018-12-12 2021-07-29 Medibeacon Inc Uses of transdermal glomerular filtration rate measurement in continuous renal replacement therapy
WO2021016133A1 (en) * 2019-07-19 2021-01-28 Washington University Particle-based method for defining a gut microbiota in humans or other animal species
GB202001336D0 (en) 2020-01-31 2020-03-18 Imp College Innovations Ltd Methods for measuring gut permeability and gastric emptying rate
CN116348755A (zh) * 2020-07-24 2023-06-27 麦迪贝肯有限公司 用于胃肠功能家庭经皮评估的系统和方法
US20220326255A1 (en) * 2021-04-01 2022-10-13 Medibeacon Inc. Methods of monitoring mucosal healing

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6909912B2 (en) 2002-06-20 2005-06-21 University Of Florida Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes
US7430445B2 (en) 2003-04-24 2008-09-30 The Board Of Regents Of The University Of Texas System Noninvasive blood analysis by optical probing of the veins under the tongue
US20060095102A1 (en) 2003-09-17 2006-05-04 Thomas Perez Method and apparatus for sublingual application of light to blood
CN101010107A (zh) 2004-08-26 2007-08-01 马林克罗特公司 监测肾功能的发光金属络合物
JP2008525487A (ja) 2004-12-23 2008-07-17 マリンクロッド・インコーポレイテッド 蛍光ピラジン誘導体および腎機能評価におけるその使用方法
WO2007002332A2 (en) 2005-06-21 2007-01-04 Mallinckrodt Inc. Optical imaging contrast agents
CA2628661A1 (en) * 2006-06-22 2007-12-27 Mallinckrodt Inc. Pyrazine derivatives and uses thereof in renal monitoring
TWI327369B (en) * 2006-08-07 2010-07-11 Chipmos Technologies Inc Multichip stack package
CN1966086A (zh) * 2006-11-22 2007-05-23 重庆大学 一种获取药物消化道吸收特性的方法
CN101687040A (zh) * 2007-03-01 2010-03-31 马林克罗特公司 整合光活性的小分子及其用途
WO2009002533A1 (en) * 2007-06-27 2008-12-31 The Brigham And Women's Hospital, Inc. Inflammatory bowel disease therapies
JP2010535240A (ja) 2007-07-31 2010-11-18 マリンクロッド・インコーポレイテッド 一体化光活性薬剤およびその使用
WO2009021064A1 (en) 2007-08-06 2009-02-12 University Of Rochester Medical apparatuses incorporating dyes
US9632094B2 (en) 2008-08-22 2017-04-25 Norbert Gretz Transcutaneous organ function measurement
EP2376459B1 (en) 2008-12-17 2015-02-18 MediBeacon, LLC Modified pyrazine derivatives and uses thereof
US8628751B2 (en) 2009-04-16 2014-01-14 Medi Beacon Development, LLC Pyrazine derivatives for optical imaging and therapy
JP5817073B2 (ja) 2010-01-28 2015-11-18 国立大学法人三重大学 新規インドシアニン化合物を用いた診断用組成物及び分析方法
US20130101513A1 (en) 2010-03-16 2013-04-25 Xiaojian Yang Method of using near infrared fluorescent dyes for imaging and targeting cancers
WO2011161220A1 (en) 2010-06-23 2011-12-29 Photocure Asa Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
JP5768294B2 (ja) 2010-10-22 2015-08-26 学校法人福岡大学 胃上皮性腫瘍（腺腫・胃癌）の診断に有用な白色不透明物質を応用した診断能改善用組成物
US20120172678A1 (en) 2010-12-30 2012-07-05 Logan Robert J Systems and methods for monitoring and processing biometric data
WO2012149227A2 (en) 2011-04-26 2012-11-01 Incube Labs, Llc Mouthpiece for measurement of biometric data of a diver and underwater communication
WO2013106656A2 (en) 2012-01-12 2013-07-18 University Of Connecticut Methods of treating adverse intestinal effects of nonsteroidal anti-inflammatory drugs
US20130216482A1 (en) 2012-02-03 2013-08-22 The Board Of Regents Of The University Of Texas System Methods and compositions for non-invasive, dynamic imaging of intestinal motility

Also Published As

Publication number Publication date
CN110237273A (zh) 2019-09-17
US12048751B2 (en) 2024-07-30
CN110237273B (zh) 2022-05-06
EP3068399A1 (en) 2016-09-21
US20150147277A1 (en) 2015-05-28
IL245602B1 (en) 2023-11-01
EP3068399B1 (en) 2021-06-30
US20220241438A1 (en) 2022-08-04
IL245602B2 (en) 2024-03-01
AU2014346386A1 (en) 2016-06-02
CN110251691A (zh) 2019-09-20
IL245602A0 (en) 2016-06-30
WO2015070256A1 (en) 2015-05-14
US20190142976A1 (en) 2019-05-16
CN105873590A (zh) 2016-08-17
EP3068399A4 (en) 2017-06-07
CA2930387C (en) 2023-02-14
JP2020073517A (ja) 2020-05-14
NZ719971A (en) 2022-05-27
JP6961670B2 (ja) 2021-11-05
JP2022009085A (ja) 2022-01-14
EP3733183A1 (en) 2020-11-04
US11285224B2 (en) 2022-03-29
JP2016535102A (ja) 2016-11-10
US20190091348A1 (en) 2019-03-28
US11285223B2 (en) 2022-03-29
CN105873590B (zh) 2021-05-28
AU2014346386B2 (en) 2020-04-02
CN112717146A (zh) 2021-04-30
US11077211B2 (en) 2021-08-03
CA2930387A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
MX2016006165A (es) Composiciones y metodos para valorar la funcion intestinal.
HK1243333A1 (zh) 用於修飾的t細胞的方法和組合物
HK1253306A1 (zh) 抗ntb-a抗體及相關組合物和方法
DK3390631T3 (da) Fremgangsmåder og sammensætninger til t-rna-baseret guide-rna-ekspression
DK3245225T3 (da) Sammensætninger og fremgangsmåder til behandling og detektering af cancere
IL287607A (en) Preparations, kits and methods for inducing acquired cellular resistance using inducible stress proteins
DK3125927T3 (da) Fremgangsmåder og sammensætninger til immunmodulering
KR20180084891A (ko) 구조 조성물 및 방법
HK1244317A1 (zh) Ibs敏感度測試的組合物、設備以及方法
DK3123381T3 (da) Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer
DK3384287T3 (da) Forbedrede cytometriske analyser
DK3324932T3 (da) Sammensætninger og fremgangsmåder for nanopartikel lyofile former
DK3013326T3 (da) Skaldannende sammensætninger til bløde kapsler og bløde kapsler
BR112016019822A2 (pt) Determinação enzimática de hba1c
IL257049A (en) Compositions and methods for measuring blood glucose levels
FI3511422T3 (fi) Menetelmiä ja koostumuksia endometriooosin diagnosointia, ennustamista ja hoitoa varten
DK3364189T3 (da) Immunkromatografisk teststykke
EA201891478A1 (ru) Способы и композиции для оценки риска возникновения рака
DK3331498T3 (da) Nasalsammensætning
DK2968220T3 (da) Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
HK1257421A1 (zh) Bag3 組合物和方法
DK3551617T3 (da) Sammensætninger og fremgangsmåder relateret til pyridinodylpiperidin-5-HT1F-agonister
EP2959292A4 (en) METHOD AND COMPOSITIONS FOR THE ASSESSMENT OF LUNG TRANSPLANTS
ES1191683Y (es) Tapon multiflujo
DK3350318T3 (da) Fremgangsmåder relateret til aktiverede dendritiske cellesammensætninger til individer med fremskredne cancersygdomme